1 – 10 of 64
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Impact of site-specific conjugation strategies on the pharmacokinetics of antibody conjugated radiotherapeutics
(
- Contribution to journal › Article
-
Mark
Beyond Average : a-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate Cancer
(
- Contribution to journal › Article
- 2023
-
Mark
Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response
(
- Contribution to journal › Article
- 2022
-
Mark
Prostate cancer polygenic risk score and prediction of lethal prostate cancer
(
- Contribution to journal › Article
- 2021
-
Mark
Improved 223Ra Therapy with Combination Epithelial Sodium Channel Blockade
(
- Contribution to journal › Article
-
Mark
PSA-Targeted Alpha-, Beta-, and Positron-emitting immunotheranostics in murine prostate cancer models and nonhuman primates
(
- Contribution to journal › Article
- 2020
-
Mark
Preclinical Single Photon Emission Computed Tomography of Alpha Particle-Emitting Radium-223
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies novel single nucleotide polymorphisms having age-specific effect on prostate-specific antigen levels
(
- Contribution to journal › Article
-
Mark
Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy
2020) In Proceedings of the National Academy of Sciences of the United States of America 117(26). p.15172-15181(
- Contribution to journal › Article
- 2019
-
Mark
Harnessing androgen receptor pathway activation for targeted alpha particle radioimmunotherapy of breast cancer
(
- Contribution to journal › Article